Motor changes during sertraline treatment in depressed patients with Parkinson’s disease
✍ Scribed by J. Kulisevsky; J. Pagonabarraga; B. Pascual-Sedano; A. Gironell; C. García-Sánchez; M. Martínez-Corral
- Book ID
- 111065570
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 95 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1351-5101
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Although antidepressant medications are commonly used to treat depression in Parkinson's disease (PD), little information is available regarding their safety and efficacy in this condition. Sertraline is a relatively selective serotonin reuptake inhibitor with some dopamine reuptake inh
## Abstract Impaired initiation and slowed execution of movements are two of the principal characteristics of Parkinson's disease (PD). A similar pattern of movement impairments (psychomotor retardation) can be seen frequently in patients with idiopathic depression. In addition, affective disorders
Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control